Lingping Huang
Overview
Explore the profile of Lingping Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ding L, Xu F, Luo B, Cheng L, Huang L, Jia Y, et al.
Int J Nanomedicine
. 2024 May;
19:4589-4605.
PMID: 38799695
Background: Medical imaging modalities, such as magnetic resonance imaging (MRI), ultrasound, and fluorescence imaging, have gained widespread acceptance in clinical practice for tumor diagnosis. Each imaging modality has its own...
2.
Huang L, He X, Zuo X
J Immunol Res
. 2022 Aug;
2022:1932692.
PMID: 35979255
Objective: To investigate the effect and mechanism of curcumin (CUR) killing lung cancer HCC827 cell spheres. Method: HCC827 cell spheres were cultured in serum-free medium, and the protein expression of...
3.
Wang H, Ding L, Xu F, He L, Ye L, Huang L, et al.
J Biomater Appl
. 2021 Apr;
36(4):613-625.
PMID: 33899561
In this experiment, a new amphiphilic chitosan-poly(lactide) graft copolymer was synthesized and characterized by IR, H-NMR, XRD, TGA. The obtained chitosan-poly (lactide) graft copolymer was used as the matrix material...
4.
Ding J, Zhao Z, Song J, Luo B, Huang L
Acta Biochim Biophys Sin (Shanghai)
. 2018 Apr;
50(6):597-604.
PMID: 29701752
Although doxorubicin has become a key drug in cancer treatment, the resistance of colorectal carcinoma to doxorubicin is a major problem in clinical practice. F-box and WD repeat domain-containing 7...